您要查找的是不是：
- The HLA (Human Leukocyte Antigen) is the major antigenic system of histocompatibility in human . 人類(lèi)白細胞抗原)是人類(lèi)主要組織相容性抗原系統.
- The presence of human leukocyte antigen (HLA) antibodies has been negatively associated with transplant outcome. 而人白細胞抗原（HLA）抗體的存在會(huì )對移植效果產(chǎn)生反作用。
- Objective: To study the origin of Sichuan Yi ethnic group according to human leukocyte antigen(HLA)-B gene frequency. 目的:根據人類(lèi)白細胞抗原(HLA)-B基因頻率,探討四川彝族的民族起源。
- Objective To evaluate the relationship between atherosclerotic brain infarction (ABI) and human leukocyte antigen DR (HLA-DR) gene at molecular level. 目的探討人白細胞DR抗原(HLA DR)基因與動(dòng)脈粥樣硬化性腦梗死(ABI)免疫遺傳的相關(guān)性。
- Conclusion There are abnormal human leukocyte antigen DR expression on T lymphocyte and its subsets in patients with acute myocardial infarction. 提示急性心肌梗死患者T淋巴細胞表達白細胞－DR抗原異常。
- Human leukocyte antigen(HLA)-G is the non-classical human major histocompatibility complex(MHC),having limited polymorphism. HLA-G作為一種人類(lèi)的主要組織相容性復合體,具有限多態(tài)性。
- Human Leukocyte Antigen (HLA) antibodies posttransplant have been associated with an increased risk of early graft failure in kidney transplants. 移植后人白細胞抗原（HLA）抗體與腎移植后早期移植物失功的高危相關(guān)。
- Objective:To study the effects of intercellular adhesion molecule 1 (ICAM 1) and human leukocyte antigen (HAL DR) on the immunopathologic process of uveitis. 目的：研究細胞間粘附分子?1（intellular adhesion m olecule?1， I C A M ?1）和人體組織相關(guān)抗原（hum an leukocyte antigen， H L A? D R）在葡萄膜炎免疫反應中的作用。
- Inadequate recognition of fetal antigens or increased sharing of human leukocyte antigens with the father may inhibit the production of anti-HLA antibodies. 母體對胎兒抗原的錯誤識別或與父方的HLA相容性增高，都會(huì )抑制其抗-HLA抗體的產(chǎn)生。
- Objective: To investigate the function and significance of human leukocyte antigen-G(HLA-G) protein in human preimplantation embryos and immunological tolerance. 摘要目的：探討HLA-G在人類(lèi)胚胎早期發(fā)育和免疫耐受中的作用和意義。
- AIM: To observe the dynamic changes in human leukocyte antigen DR (HLA-DR) antigen presentation on peripheral blood lymphocyte (PBL) of patients with postoperative pneumonia after renal transplantation and the curative efficacy of compound Qingrekeli. 目的:觀(guān)察腎移植術(shù)后肺炎患者外周血淋巴細胞表面HLA-DR抗原表達的動(dòng)態(tài)變化及中藥復方清熱顆粒的治療效果。
- The immunological indexes were determined before and after therapy on the 1 st, 3 rd, 7 th, 14 th and 28 th day, including the changes in lymphocyte count, CD14~+ monocytes human leukocyte antigen (locus) DR (HLADR), clinical data and long-term follow-up. 分別觀(guān)察治療前及治療后1、3、7、14和28d淋巴細胞計數和CD14+單核細胞人白細胞DR抗原(HLA DR)水平等相關(guān)免疫學(xué)指標動(dòng)態(tài)變化,并收集臨床資料和遠期隨訪(fǎng)。
- Usually, human leukocyte antigen typing was done before kidney removal and the recipient was evaluated in the evening or at night for a transplant procedure starting in the morning. 通常，人白細胞抗原類(lèi)型檢測在供腎切取前已經(jīng)完成，受者準備工作在傍晚或夜晚，第二天早晨進(jìn)行移植。
- It's only human nature to want a comfortable life. 想過(guò)舒適的生活不過(guò)是普通人的本性。
- Human leukocyte antigen DR expression on monocytes 單核細胞人類(lèi)白細胞抗原DR
- Human leukocyte antigen class I antigen HLA-I類(lèi)分子
- Human leukocyte antigen class Ⅱ 人類(lèi)白細胞抗原Ⅱ類(lèi)復合體
- Human leukocyte antigen classⅡgenes 人類(lèi)白細胞抗原基因
- Human leukocyte antigen haplotype 人類(lèi)白細胞抗原半相合
- Human leukocyte antigen-DPBlgene 人類(lèi)白細胞抗原-DPB1基因
